Aims To evaluate the prognosis of patients >80 years old, we analysed a large, community-based population with acute myocardial infarction who received intensive observation and similar pharmacotherapy regardless of age.
Introduction
In 1836, the Belgian statistician Quetelet, in one of the first publications of vital statistics, concluded 'From sixty to sixty-five years of age viability loses much of its energy, that is to say, the probability of life then becomes very small' 1 ' 1 . Since then, investigators in clinical medicine have continued to try to establish an age limit to define an old age group with an inferior life prognosis. Despite the fact that between one-third and a half of acute myocardial infarction cases are patients more than 70 years old (admitted to American and European university-affiliated hospitals' 2^1 '), more than 60% of trials on randomized therapy in acute myocardial infarction excludes patients above this age [5] .
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Prejudice about the relative life expectancy and treatment potential may be part of the reason why effective treatments are used less frequently and have not been investigated as thoroughly in older patients' 236 " 91 . In contemporary management of acute myocardial infarction, patients in their 70s are probably as intensively treated as their younger counterparts. It would seem that the decision to treat some patients differently, because of a perceived hopeless prognosis on the grounds of age alone, mostly operates when the patient, in simplified terms, is 80 years old or more. This age group has seldom been analysed separately and, in most reports, is not large. Moreover, much recent information is based on randomized trials, and have thus used data from highly selected patients' 10 " 121 .
The purpose of the current study was to evaluate the outcome of old patients, especially those with potentially reversible complications, represented by heart failure and ventricular fibrillation. These conditions may be regarded as the primary traditional targets of intensive observation and therapy after acute myocardial infarction. tPatients without heart failure who died on the first day of admission were excluded from Killip class 1 (see text).
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Methods
All consecutive patients with acute myocardial infarction admitted alive to Glostrup County Hospital in the 12-year period between 1977 and 1988 were studied. The hospital serves approximately 250 000 people in an urban district of Copenhagen, Denmark. All patients with suspected acute myocardial infarction, irrespective of age, were admitted to the Coronary Care Unit. During the period of the study a single senior physician registered all admission details so as to create a database of consecutive myocardial infarction cases, although the end-points of the study were not defined. The diagnosis of acute myocardial infarction was made according to WHO criteria. Details were taken of any history or new finding of diabetes mellitus or hypertension, the presence of heart failure (at any point during hospitalization) and its severity (divided into Killip class l-4
[l3] ), and the occurrence of ventricular fibrillation, heart arrest with asystole, or atrial fibrillation. The diagnostic criteria were constant and have been described in detail previously'
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At the beginning of the study period, patients were admitted and their ECGs continuously monitored for at least 18 days, corresponding to a mean hospitalization time of 14-1 days owing to in-hospital fatalities. After 1982, the mean hospitalization time was reduced to 11-3 days. This is detailed in another report from the same institution 1 ' 51 . In patients experiencing more than one hospital admission in the study period, only data concerning the first admission were used. Survival data at discharge, and at 1 and 5 years post-discharge were obtained from patient files and from the Danish Central Personal Register, where all deaths in Denmark are registered. Survival data were available for all patients.
Intravenous thrombolysis was not introduced during the study period, and aspirin, beta-blocking or ACE inhibitory drugs were not prescribed for the specific indication of acute myocardial infarction or heart failure.
Data analysis
Survival data with confidence intervals for 1 and 5 years are Kaplan-Meier estimates. A multivariate analysis of influence by the clinical variables mentioned above on post-discharge mortality, both during the first year post-discharge and during available post-discharge follow-up, was performed with proportional hazard models. In this analysis, Killip classes 2-4 were compared one at a time with Killip class 1. Age was analysed as a continuous variable by 1-year increments. The SAS software (SAS Institute, Cary, NC, U.S.A.) was used for computing the statistics.
Results
Selected demographic data and in-hospital complications are listed in Table 1 .
Patients without a diagnosis of heart failure had an unexpected high mortality. Of the patients who did not survive the first 24 h of hospitalization (i.e. dying on the calender day of admission, or the following day), 255 (43%) did not obtain a diagnosis of heart failure. These patients were excluded from Killip class 1, because the diagnosis of heart failure was probably missed in many cases. This manipulation of the Killip classification tends to underestimate the in-hospital mortality of patients in Killip class 1, but does not influence data on post-discharge mortality.
In-hospital clinical heart failure became increasingly more common and severe the more advanced the age group (Table 1) . Two-thirds of patients 80 years or older had heart failure. The overall in-hospital mortality was 23%; mortality was 11% for patients less than 50 years of age, 22% for patients in the largest age group 60-69 years old and 43% for patients 80 years or older ( Table 2 ). The figures for 1-year post-discharge mortality were 9%, 18% and 44%, respectively (Table 3) ; 5 year post-discharge mortality is presented in Table 4 .
Mortality at any time after the acute myocardial infarction was generally higher the older the age group when the patients belonged to the same Killip class. This effect of age was most pronounced in the absence of heart failure (Killip class 1), but less so with any degree of heart failure (Killip class 2-4).
Mortality, both during hospitalization and for those discharged alive, was much higher in patients with any degree of heart failure, although relatively less so in older age groups. Cardiogenic shock was twice as common in patients 80 years or older than in patients 60-69 years old, and four times as common as in patients less than 50 years old. Patients with cardiogenic shock suffered a massive excess mortality while hospitalized; in all age groups cardiogenic shock was associated with about half (42-56%) of in-hospital deaths.
The occurrence of in-hospital ventricular fibrillation was not significantly different between the age groups. With this complication, mortality was higher in the older age groups. Four out of eight patients 80 years or older that had survived in-hospital ventricular fibrillation also survived one year.
The results of multivariate analysis is presented in Table 5 . Age was a highly significant (P=00001) independent predictor of mortality both during the first year post-discharge and during all available postdischarge follow-up (risk ratio = 1 04 per one-year increment). Heart failure (as Killip classes 2-4) was the most important independent risk factor. This was also true when each of the age strata were analysed separately (with all available follow-up). Atrial fibrillation had a very weak independent contribution to mortality which was only significant (P=0-04) using all available follow-up.
Discussion
The overall in-hospital mortality of 23% in this study is similar to or somewhat higher than in other studies of post-myocardial infarction prognosis in unselected patients from the same time period. For example, in the Worcester Heart Attack Study in-hospital mortality declined from 22% to 1975 to 17% in 1981 (age-adjusted for the population composition in 1980) t16 '. The higher in-hospital mortality may be explained by the relatively long duration of hospitalization in our study and a conservative policy with regard to the introduction of beta-blockers for secondary prophylaxis after myocardial infarction. Killip class=see Table 1 ; VF = ventricular fibrillation; AF=atrial fibrillation.
Other studies of age-related outcome after acute myocardial infarction have uniformly reported increased short-term [ 201 . Although our results show a higher mortality for patients with this complication, it was associated with a very weak independent contribution to adverse prognosis. In another large myocardial infarction population from the same era, atrial fibrillation had no independent impact on in-hospital mortality when adjusted for other risk factors' 201 . It has been reported that cardiac rupture has a higher incidence in old patients, but is under-represented as a cause of death among them' 2 ' 1 . However, this may be different after thrombolysis, as in GISSI-2 cardiac rupture has been found in 86% of deceased patients of more than 70 years old undergoing autopsy' 101 . Second or third degree atrioventricular block is not more frequent among the elderly in most' , reports. Ventricular fibrillation in this and earlier studies is equally common in younger and older age groups' 2 -6 -171 in GISSI-2" 01 , however, it was a less frequent cause of death among the older patients.
As is evident from our results, the elderly more often present with in-hospital clinical heart failure, which is also a ubiquitous finding in previous reports' 2 -6 -9 -' 2 ' 17 ' 181 . Heart failure was associated with considerable excess mortality for both younger and older age groups. The life-saving potential of preventing or reducing heart failure in the oldest age groups has been reflected in clinical trials of the efficacy of thrombolytic drugs' 221 and ACE inhibitors' 231 . It has previously been shown that the frequency of heart failure and the higher mortality in older patients is not explained by the size, location, or type of infarct: peak serum concentrations of myocardial enzymes are equal' 3 2 ' 9 '" 1 . Even in the absence of clinical heart failure, mortality in our study is higher in older than in younger patients, which confirms tendencies in other studies (that do not specify statistical significance)' 9111 . When analysed in multivariate models that include risk factors of medical history, markers of myocardial infarction size and distribution, and infarct complications, age has been found to be an independent predictor of mortality' Whereas none of the most efficient contemporary therapies for heart failure were given to the patients in the current study, treatment of ventricular fibrillation was probably as efficient as that practiced today. Since the patients surviving ventricular fibrillation would probably have died, if not monitored and promptly treated with electrical defibrillation during hospitalization, the 32% of patients 80 years or older with ventricular fibrillation surviving hospitalization in this study represent an absolute survival benefit of monitoring in a coronary care unit. Half of these patients survive 1 year, making it difficult to justify treatment refusal in this patient group -even though 87 patients from the age group in question had to be monitored for ventricular fibrillation to save one patient with this complication after one year. Additional benefits are to be expected from optimized treatment in a coronary care unit; nevertheless, one-fifth of coronary care units in Great Britain operated an age-related admission policy in ,991 (25] 
Limitations
The identification of the complications analysed have the inaccuracy inherent with retrospective analysis, but set against this, as described above, is the systematic collection of diagnoses by strict and uniform criteria. Inclusion of only those patients admitted alive may underestimate both incidence of myocardial infarction and mortality among old age groups, since, in one study' 181 , 44% of patients 75 years or older with acute myocardial infarction confirmed at autopsy, were dead on arrival at hospital, compared to 23% below that age.
The long sample time and long-term follow-up result in differences between therapies practiced currently and in the study period and thus make the complications and prognosis of the patients in this study different from those of today.
Conclusion
Mortality after acute myocardial infarction increases with age which remains an independent risk factor, among several others, in multivariate analysis. The life-saving potential of preventing or treating heart failure among old patients with acute myocardial infarction seems large. Monitoring patients 80 years or older for correction of ventricular fibrillation produces an acceptable prognosis of patients discharged alive after this complication.
